Diagnosis and Management of Castleman Disease Blastic
Total Page：16
File Type：pdf, Size：1020Kb
cancercontroljournal.org Vol. 21, No. 4, October 2014 H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, AN NCI COMPREHENSIVE CANCER CENTER Diagnosis and Management of Castleman Disease Jacob D. Soumerai, MD, Aliyah R. Sohani, MD, and Jeremy S. Abramson, MD Blastic Plasmacytoid Dendritic Cell Neoplasm: Update on Molecular Biology, Diagnosis, and Therapy Wasif Riaz, MD, Ling Zhang, MD, Pedro Horna, MD, et al Dendritic Cell and Histiocytic Neoplasms: Biology, Diagnosis, and Treatment Samir Dalia, MD, Haipeng Shao, MD, PhD, Elizabeth Sagatys, MD, et al Hereditary and Acquired Hemophagocytic Lymphohistiocytosis Ling Zhang, MD, Jun Zhou, MD, and Lubomir Sokol, MD, PhD Pathogenesis, Diagnosis, and Management of Kikuchi–Fujimoto Disease Darcie Deaver, PhD, Pedro Horna, MD, Hernani Cualing, MD, et al Rosai–Dorfman Disease: Tumor Biology, Clinical Features, Pathology, and Treatment Samir Dalia, MD, Elizabeth Sagatys, MD, Lubomir Sokol, MD, PhD, et al Langerhans Cell Histiocytosis Nanette Grana, MD Transplantation in Rare Lymphoproliferative and Histiocytic Disorders Alexis Cruz-Chacon, MD, John Mathews, MD, and Ernesto Ayala, MD Cancer Control is included in Index Medicus/MEDLINE Permit No. 4390 No. Permit Tampa FL 33612-9416 FL Tampa Jacksonville, FL Jacksonville, 12902 Magnolia Drive Magnolia 12902 PAID & RESEARCH INSTITUTE INC INSTITUTE RESEARCH & Nonprofit Org. Nonprofit CENTER CANCER MOFFITT LEE H advances in the management of multiple Save the Date! presents Advances in the Management of Multiple Myeloma March 6–7, 2015 Loews Don Cesar Hotel St. Petersburg Beach, Florida Course Directors: Melissa Alsina, MD, Rachid Baz, MD, and Kenneth H. Shain, MD, PhD Moffitt Cancer Center, Tampa, Florida Conference Overview: Advances in the Management of Multiple Myeloma conference is designed to foster the exchange of the most recent advances in the biology and treatment of multiple myeloma. National and international leading experts in the field will present in a format promoting discussion and interaction with participants. Target Audience: This educational program is directed toward hematologists, medical and surgical oncologists, and BMT physicians who diagnose, treat, and manage multiple myeloma. Other health care professionals who are interested in the diagnosis, treatment, and care of patients with multiple myeloma are also invited to attend. To be added to the conference mailing list, contact: Moffitt Cancer Center | Marsha Moyer, MBA | 813-745-2286 | [email protected] Editorial Board Members Editor: Rami Komrokji, MD Production Staff: Associate Member Lodovico Balducci, MD Veronica Nemeth Malignant Hematology Senior Member Editorial Coordinator Conor C. Lynch, PhD Program Leader, Senior Adult Oncology Program Don Buchanan Assistant Member Moffitt Cancer Center Graphic Designer Tumor Biology Deputy Editor: Amit Mahipal, MD, MPH Consultant: Julio M. Pow-Sang, MD Assistant Member Clinical Research Unit Sherri Damlo Senior Member Medical Copy Editor Chair, Department of Genitourinary Oncology Gastrointestinal Oncology Director of Moffitt Robotics Program Kristen J. Otto, MD Associate Editor of Moffitt Cancer Center Assistant Member Head & Neck Oncology Educational Projects Editor Emeritus: Michael A. Poch, MD John M. York, PharmD Akita Biomedical Consulting John Horton, MB, ChB Assistant Member 1111 Bailey Drive Professor Emeritus of Medicine & Oncology Genitourinary Oncology Paso Robles, CA 93446 Jeffery S. Russell, MD, PhD Phone: 805-238-2485 Moffitt Cancer Center Assistant Member Fax: 949-203-6115 Journal Advisory Committee: Endocrine Tumor Oncology E-mail: [email protected] Aliyah Baluch, MD Elizabeth M. Sagatys, MD Assistant Member Assistant Member For Consumer and Infectious Diseases Pathology - Clinical General Advertising Dung-Tsa Chen, PhD Jose E. Sarria, MD Information: Associate Member Assistant Member Veronica Nemeth Biostatistics Anesthesiology Editorial Coordinator Hey Sook Chon, MD Saïd M. Sebti, PhD Cancer Control: Assistant Member Senior Member Journal of the Moffitt Cancer Center Gynecological Oncology Drug Discovery 12902 Magnolia Drive – MBC-JRNL Tampa, FL 33612 Jasreman Dhillon, MD Bijal D. Shah, MD Phone: 813-745-1348 Assistant Member Assistant Member Fax: 813-449-8680 Pathology - Anatomic Malignant Hematology E-mail: [email protected] Jennifer S. Drukteinis, MD Lubomir Sokol, MD, PhD Associate Member Senior Member Diagnostic Radiology Hematology/Oncology Timothy J. George, PharmD Hatem H. Soliman, MD Pharmacy Residency Director Assistant Member Clinical Pharmacist - Malignant Hematology Breast Oncology Clement K. Gwede, PhD Jonathan R. Strosberg, MD Associate Member Assistant Member Health Outcomes & Behavior Gastrointestinal Oncology Sarah E. Hoffe, MD Sarah W. Thirlwell, RN Associate Member Nurse Director Radiation Oncology Supportive Care Medicine Program Cancer Control is a member of John V. Kiluk, MD Eric M. Toloza, MD, PhD the Medscape Publishers’ Circle®, Associate Member Assistant Member an alliance of leading medical Breast Oncology Thoracic Oncology publishers whose content is Richard D. Kim, MD Nam D. Tran, MD featured on Medscape Associate Member Assistant Member (www.medscape.com). Gastrointestinal Oncology Neuro-Oncology Bela Kis, MD, PhD Jonathan S. Zager, MD Most issues and supplements of Assistant Member Associate Member Cancer Control are available at Diagnostic Radiology Sarcoma and Cutaneous Oncology cancercontroljournal.org CANCER CONTROL: JOURNAL OF THE MOFFITT CANCER CENTER (ISSN 1073-2748) is published by H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612. Telephone: 813-745-1348. Fax: 813-449-8680. E-mail: [email protected]. Internet address: cancercontroljournal.org. Cancer Control is included in Index Medicus ®/MEDLINE® and EM- BASE®/Excerpta Medica, Thomson Reuters Science Citation Index Expanded (SciSearch®) and Journal Citation Reports/Science Edition. Send subscription requests to the publisher. Single copy: $10 US, $15 Canada and foreign. Subscription rates: nonqualified individuals $60 per year US, $75 per year outside US, institutions/libraries $120 per year US ($135 per year foreign). Send change of address to the publisher with old address label and new address. Publisher is not responsible for undelivered copies. Copyright 2014 by H. Lee Moffitt Cancer Center & Research Institute. All rights reserved. Printed on acid-free paper. Cancer Control: Journal of the Moffitt Cancer Center is a peer-reviewed journal that is published to enhance the knowledge needed by professionals in oncology to help them minimize the impact of human malignancy. Each issue emphasizes a specific theme relating to the detection or management of cancer. The objectives of Cancer Control are to define the current state of cancer care, to integrate recently generated information with historical practice patterns, and to enlighten readers through critical reviews, commentaries, and analyses of recent research studies. DISCLAIMER: All articles published in this journal, including editorials and letters, represent the opinions of the author(s) and do not necessarily reflect the opinions of the editorial board, the H. Lee Moffitt Cancer Center & Research Institute, Inc, or the institutions with which the authors are affiliated unless clearly specified. The reader is advised to independently verify the effectiveness of all methods of treatment and the accuracy of all drug names, dosages, and schedules. Dosages and methods of administration of pharmaceutical products may not be those listed in the package insert and solely reflect the experience of the author(s) and/or clinical investigator(s). October 2014, Vol. 21, No. 4 Cancer Control 257 Table of Contents Editorial Hope for Orphan Lymphoproliferative and Histocytic Diseases on the Horizon? 260 Lubomir Sokol, MD, PhD Articles Diagnosis and Management of Castleman Disease 266 Jacob D. Soumerai, MD, Aliyah R. Sohani, MD, and Jeremy S. Abramson, MD Blastic Plasmacytoid Dendritic Cell Neoplasm: 279 Update on Molecular Biology, Diagnosis, and Therapy Wasif Riaz, MD, Ling Zhang, MD, Pedro Horna, MD, and Lubomir Sokol, MD, PhD Dendritic Cell and Histiocytic Neoplasms: 290 Biology, Diagnosis, and Treatment Samir Dalia, MD, Haipeng Shao, MD, PhD, Elizabeth Sagatys, MD, Hernani Cualing, MD, and Lubomir Sokol, MD, PhD Hereditary and Acquired Hemophagocytic Lymphohistiocytosis 301 Ling Zhang, MD, Jun Zhou, MD, and Lubomir Sokol, MD, PhD Pathogenesis, Diagnosis, and Management of 313 Kikuchi–Fujimoto Disease Darcie Deaver, PhD, Pedro Horna, MD, Hernani Cualing, MD, and Lubomir Sokol, MD, PhD Rosai–Dorfman Disease: Tumor Biology, Clinical Features, 322 Pathology, and Treatment Samir Dalia, MD, Elizabeth Sagatys, MD, Lubomir Sokol, MD, PhD, and Timothy Kubal, MD 258 Cancer Control October 2014, Vol. 21, No. 4 Table of Contents Langerhans Cell Histiocytosis 328 Nanette Grana, MD Transplantation in Rare Lymphoproliferative and 335 Histiocytic Disorders Alexis Cruz-Chacon, MD, John Mathews, MD, and Ernesto Ayala, MD Departments Special Report: Social Determinants of Racial and Ethnic Disparities in 343 Cutaneous Melanoma Outcomes Valerie M. Harvey, MD, Hitesh Patel, MS, MBA, Sophia Sandhu, MD, Sherrie Flynt Wallington, PhD, and Ginette Hinds, MD Special Report: Fruit and Vegetable Intake Among Jordanians: 350 Results From a Case-Control Study of Colorectal Cancer Reema F. Tayyem, PhD, Ihab Shehadah, MD, Suhad S. Abu-Mweis, PhD, Hiba A. Bawadi, PhD, Kamal E. Bani-Hani, MD, PhD, Tareq Al-Jaberi, MD, PhD,